Report: Cardiolite continues to dominate radiopharmaceutical market

11/11/2008 | PharmaLive.com

Cardiolite, Lantheus Medical Imaging's myocardial perfusion imaging agent, had 15% more of the market share than Myoview, a similar product from General Electric, in September, according to a report from market research firm Arlington Medical Resources. The report also said patient use of Astellas Pharma's pharmacologic stress agent, Lexiscan, increased 58.5% from August 2008 to September 2008.

View Full Article in:

PharmaLive.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC